CRT 2026

SHEATHS, ACCESS, CLOSE, WIRES AND CROSSING CATHETERS, RADIAL TO PERIPHERAL

Facilitator(s)

• 

  George Adams, MD MHS MBA FACC FSCAI

  Chief Medical Officer, Cordis
  Cordis, North Carolina, United States

  Disclosure information not submitted.
• 

  Karim Al-Azizi, MD, FACC, FSCAI, FESC

  Medical Director, Cardiac Catheterization Laboratories
  The Heart Hospital, Baylor Scott & White Health Baylor Scott & White
  Frisco, Texas, United States

  Disclosure information not submitted.
• 

  Ziad Ali, MD, DPhil

  Director
  DeMatteis Cardiovascular Institute
  Columbia University
  Roslyn, New York, United States

  Disclosure information not submitted.
• 

  Marianne Brodmann, MD

  Head of Divsion of Angiology, Medical University Graz
  Medical University Graz
  Graz, Steiermark, Austria

  Disclosure(s): No financial relationships to disclose
• 

  George Chrysant, MD

  Chief Medical Officer
  INTEGRIS Cardiovascular Physicians, LLC
  Oklahoma City, Oklahoma, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Acarix: Chief Medical Advisor (Ongoing); philips,shockwave,penumbra: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Eric J. Dippel, MD

  Interventional Cardiologist
  Vascular Institute of the Midwest, PC
  Bettendorf, Iowa, United States

  Disclosure information not submitted.
• 

  Hayder D. Hashim, MD

  Interventional Cardiologist
  Medstar Washington Hospital Center/Georgetown University
  washington, District of Columbia, United States

  Disclosure(s): Penumbra, BD, Boston Scientific, Medtronic, Philips, Shockwave, Gore, r3Vascular, Akura, Cagent Vascular, AcoArt, Contego Medical, InspireMD, AVS, Fastwave, .Cordis, Reva Medical,: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Jihad A. Mustapha, MD FACC FSCAI

  Interventional Cardiologist
  Lorven Heart & Vascular Institute
  Ada , Michigan, United States

  Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing); Cagent Vascular: Stock Options [in privately held companies] (Ongoing); Cardioflow: board member/chief medical officer, equity ownership (Ongoing), Stock-privately held company (Ongoing); Euphrates: Stock Options [in privately held companies] (Ongoing); Glift: Stock Options [in privately held companies] (Ongoing); Iatri: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Immertec: Stock Options [in privately held companies] (Ongoing); Levee Medical: Stock Options [in privately held companies] (Ongoing); Micromedical Solutions: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Reflow Medical: Grant/Research Support (Ongoing), scientific advisory board (Ongoing), Stock-privately held company (Ongoing); SoundBite Medical: Stock-privately held company (Ongoing); Transit Medical: Stock Options [in privately held companies] (Ongoing); Versono: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Zola M. N'Dandu, MD

  Interventional Cardiology and Endovascular Specialist
  MILLU Cardiovascular Wellness
  St Augustine, Florida, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific, Terumo: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Venkatesh Ramaiah, MD, FACS

  Co Founder and Chief PULSE CARDIOVASCULAR INSTITUTE CHAIRMAN TEDCONGRESS CONSULTANT ARIZONA HEART INSTITUTE OSBORN MEDICAL CENTER
  Pulse Cardiovascular Institute
  Scottsdale, Arizona, United States

  Disclosure information not submitted.
• 

  Kenneth Rosenfield, MD, MHCDS

  section head, vascular medicine and intervention
  Massachusetts General Hospital
  boston, Massachusetts, United States

  Disclosure information not submitted.
• FS

  Fadi Saab, MD

  Detroit Medical Center-Sinai Grace Hospital

  Disclosure information not submitted.
• 

  Pratik Sandesara, MD

  Interventional Cardiologist
  Emory Heart and Vascular

  Disclosure information not submitted.
• 

  Peter A. Soukas, MD, FSCAI

  Director, Vascular Medicine & Interventional PV Lab
  Brown University Health Cardiovascular Institute/ Brown Medical School
  Providence, Rhode Island, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific, Endologix, Contego Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Penumbra, BD, Boston Scientific, Medtronic, Philips, Shockwave, Gore, r3Vascular, Akura, Cagent Vascular, AcoArt, Contego Medical, InspireMD, AVS, Fastwave, .Cordis, Reva Medical,: Grant/Research Support (Ongoing)
• 

  Vinayak Subramanian, MD

  Cardiology Fellow
  UT Southwestern Medical Center
  Dallas, Texas, United States

  Disclosure information not submitted.